GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Core EBITDA Margin(%) | 12.37 | 15.67 |
What is the latest Core EBITDA Margin ratio of GUFIC BIOSCIENCES ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2025 | 12.37 |
| Mar2024 | 15.67 |
How is Core EBITDA Margin of GUFIC BIOSCIENCES Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2025 | 12.37 | -21.06 | |
| Mar2024 | 15.67 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹3,264.3 Cr | 13.2% | 11.1% | -16.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 13.2% |
11.1% |
-16.4% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses